Patients with diabetes have a 2 to 4 times higher risk of cataract development compared with the general population. Cataract remains one of the major causes of blindness in patients with diabetes. 1 The progression of diabetic retinopathy and maculopathy after phacoemulsification surgery has been a subject of debate. Some studies report an increased risk of progression, 2 whereas others report that this progression simply represents the natural course of the disease rather than a surgical outcome. 3-8 The purpose of our article is to review the recent studies on this subject for evaluation and management of patients with diabetes with concomitant cataract.
' Progression of Diabetic Retinopathy After PhacoemulsificationA systematic review of literature revealed 5 prospective case control studies in which type I and type II patients with diabetes underwent monocular phacoemulsification procedure and were followed for 6 to 12 months to study the progression of diabetic retinopathy (DR) compared with the fellow phakic nonoperated eye, when both eyes had symmetrical DR at baseline (Table 1). [4][5][6][7][8] The table summarizes the number of patients in each study, the preoperative DR stage of the operated and nonoperated eyes that progressed after cataract surgery, visual outcome, www.internat-ophthalmology.com | 155